The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2023

Filed:

Jan. 20, 2022
Applicant:

Glykon Technologies Group, Llc, Seattle, WA (US);

Inventors:

Daniel E. Clouatre, Seattle, WA (US);

Nimpan Bangun, Sumatra, ID;

Dallas L. Clouatre, Seattle, WA (US);

Assignee:

GLYKON TECHNOLOGIES GROUP, LLC, Seattle, WA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07F 13/00 (2006.01); C07C 59/265 (2006.01); A61K 31/194 (2006.01); C07F 1/00 (2006.01); C07F 3/06 (2006.01); C07F 3/02 (2006.01); C07F 3/04 (2006.01); A61P 3/00 (2006.01); A61P 19/02 (2006.01); A61P 29/00 (2006.01); A61P 19/10 (2006.01);
U.S. Cl.
CPC ...
C07F 13/005 (2013.01); A61K 31/194 (2013.01); C07C 59/265 (2013.01); C07F 1/005 (2013.01); C07F 3/02 (2013.01); C07F 3/04 (2013.01); C07F 3/06 (2013.01); A61P 3/00 (2018.01); A61P 19/02 (2018.01); A61P 19/10 (2018.01); A61P 29/00 (2018.01);
Abstract

Hydroxycitric acid-metal heterocyclic compounds with covalent characteristics are provided. The subject hydroxycitric acid compounds include monomeric hydroxycitric acid (HCA) compounds having a divalent metal, lactone forms thereof, and dimeric compound forms thereof. The monomeric HCA compound includes a divalent metal (X) bonded via a 5-membered ring to both the carboxylic acid and the hydroxy group of the central C2 carbon of the HCA. In addition, a monovalent metal (Y) can also be bonded to the carboxylic acid of C3 or C1, or to both C1 and C3. The subject dimeric compounds include monomeric HCA compounds linked via a second divalent metal (X) to a carboxylic acid group of each HCA unit at C3 or C1. Also provided are compositions including a monomeric HCA compound and one or more other additional compounds. Methods of alleviating at least one symptom associated with a target disease or condition in a subject are provided.


Find Patent Forward Citations

Loading…